Joint MHRA/DIA Excellence in Pharmacovigilance

This course is designed to provide a firm grounding in key aspects of Global and mainly European Clinical Pre- and Post-Marketing Safety regulatory requirements

戻る Agenda

INTRODUCTION

Speaker(s)

Gaby L. Danan, MD, PHD

GLD, France

Pharmacovigilance Expert

Phil Tregunno

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom